Unique ID issued by UMIN | UMIN000031703 |
---|---|
Receipt number | R000036207 |
Scientific Title | Oral Beclometasone dipropionate for for gut GVHD |
Date of disclosure of the study information | 2018/03/15 |
Last modified on | 2018/09/24 18:43:09 |
Oral Beclometasone dipropionate for for gut GVHD
BDP for gut GVHD
Oral Beclometasone dipropionate for for gut GVHD
BDP for gut GVHD
Japan |
Gut Graft-versus-host disease
Pediatrics |
Malignancy
NO
Efficacy and safety for gut GVHD to avoid the side effect of systemic steroid treatment
Safety,Efficacy
Others
Others
Not applicable
Efficacy for upper/lower digestive symptom at four
months after treatment by NIH GVHD response criteria
Interventional
Single arm
Non-randomized
Open -no one is blinded
Historical
NO
NO
Institution is not considered as adjustment factor.
NO
No need to know
1
Treatment
Medicine |
oral beclometasone treatment for four months
11 | years-old | <= |
11 | years-old | >= |
Male
a pediatric case with steroid dependent gut gVHD
no active cytomegalovirus (CMV) infection and no CMV antigenemia for confirmed endoscopically gut GVHD
1
1st name | |
Middle name | |
Last name | Satoru Hamada |
University of Ryukyus, hospital
Department of Pediatrics
207 Uehara, Nishihara, Okinawa
0988953331
shamada@med.u-ryukyu.ac.jp
1st name | |
Middle name | |
Last name | Satoru Hamada |
University of Ryukyus, hospital
Department of Pediatrics
207 Uehara, Nishihara, Okinawa
0988953331
shamada@med.u-ryukyu.ac.jp
Department of Pediatrics, University of Ryukyus, hospital
Department of Pediatrics, University of Ryukyus, hospital
Japanese Governmental office
NO
2018 | Year | 03 | Month | 15 | Day |
Unpublished
Terminated
2018 | Year | 03 | Month | 15 | Day |
2018 | Year | 03 | Month | 15 | Day |
2018 | Year | 03 | Month | 13 | Day |
2018 | Year | 09 | Month | 24 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000036207